{"symbol":"AMGN","fiscalQuarter":"Q3-2024","reportDate":"2024-10-30","reportTime":"AMC","status":"reported","company":{"name":"Amgen Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2024","postBrief":{"headline":"Amgen Beats on EPS, Stock Down 0.15%","keyNumbers":[{"metric":"EPS","actual":"$5.58","expected":"N/A","surprise":"+9.22%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key therapeutic areas.","They emphasized ongoing commitment to innovation and pipeline development."],"summary":"Overall, management expressed confidence in the company's strategic direction despite not providing specific guidance. They noted positive trends in product demand."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock dipped slightly by 0.15%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue data and future guidance may have contributed to the muted stock reaction.","metaDescription":"Amgen Inc (AMGN) Q3 2024 earnings: EPS beat by 9.22%. Stock down 0.15%. Full breakdown."}}